Conference Agenda

• M/C: Minghua Lu, MBA, Managing Partner, eChinaHealth

8:30-8:50: Registration

8:50-9:00: Opening Remarks

• Howard "Skip" Burris, III, MD, FACP, FASCO, President, Clinical Operations, Sarah Cannon Research Institute

• Ruilin Song, LLB, MBA, PhD, Chairman, China Pharmaceutical Innovation and Research Development Association (PhIRDA)

9:00-9:45: The Next Big Thing in Oncology

• Howard "Skip" Burris, III, MD, FACP, FASCO, President, Clinical Operations, Sarah Cannon Research Institute

9:45-10:30: How Technology Will Shape the Future of Cancer Care

• Steve Q. Yang, PhD, EVP and CBO, WuXi AppTec

10:30-11:00: Coffee Break

11:00-12:00: Panel Discussion: The Next Big Thing in Oncology

Panel Chair:

• George W. Sledge Jr., MD, FASCO, Professor, Medicine and Oncology, and Chief of the Division of Oncology, Stanford University Medical Center

Panelists:

• Howard "Skip" Burris, III, MD, FACP, FASCO, President, Clinical Operations, Sarah Cannon Research Institute
• Steve Q. Yang, PhD, EVP and CBO, WuXi AppTec
• Alex Casdin, MBA, CEO of Reneo Capital Management

12:00-1:30: Lunch

1:30-:1:50: AI in Discovering Hypothesis & Drug Repurposing

• Bob Battista, MBA, FRCPH, FRCP Edin, Chief Executive Officer, Doctor Evidence

1:50-:2:50: Panel Discussion: AI Healthcare

Panel Chair:

• Bob Battista, MBA, FRCPH, FRCP Edin, Chief Executive Officer, Doctor Evidence

Panelists:

• Bernard Hamelin, MD, MSc, MBA, Global Head of Medical Evidence Generation, Sanofi
• Jonathan Usuka, MBA, PhD, Leader, the Center for Analytics and Real World Evidence (CARE) for the Pharmaceutical & Medical Products practice, McKinsey & Company
• Mir Sohail Fazeli, MD, PhD, President and Managing Director, Evidinno Outcomes Research

2:50-3:10: Overview of Robotic Surgery

• Steven J. Shichman, MD, Physician in Chief, Tallwood Urology and Kidney Institute, Hartford HealthCare

3:10-4:10: Panel Discussion: Robotic Surgery

Panel Chair:

• Steven J. Shichman, MD, Physician in Chief, Tallwood Urology and Kidney Institute, Hartford HealthCare

Panelists: Senior executives of below corporations

• Gary Guthart, Ph.D, CEO, Intuitive Surgical
• Kurt Azarbarzin, President and CEO, VERB Surgical
• Bob White, MBA, Executive VP and President, Minimally Invasive Therapies Group, Medtronic
• Martin Frost, Director and Co-Founder, CMR Surgical

4:10-4:30: Coffee Break

4:30-6:00: Panel Discussion: Harnessing Technology for Innovative Cancer Care Delivery

Panel Chair:

• Yan Li, MD, Hematology/Oncology Department Chief, Kaiser Permanente Hospital

Real World Data from Real World Patients: A Technological Collaboration between Kaiser Permanente and the US FDA

• Piyush Srivastava, MD, Hematology/Oncology, Kaiser Permanente Hospital

Using Technology to Optimize Clinical Trial Engagement

• Howard "Skip" Burris, III, MD, FACP, FASCO, President, Clinical Operations, Sarah Cannon Research Institute

Technological Solutions most needed by Industry for Drug Development

• Geoff Kim, MD, Vice President, Applied Innovation, BeiGene

Using Telehealth to Provide Virtual Hematology Consultation

• Ashok Pai, MD, Clinical Leader of Benign Hematology, Kaiser Permanente

6:00-7:30: Evening Reception